Cost of medication for influenza infected elderly inpatients

Y. Hara, H. Ikematu, A. Nabeshima, Akihito Hagihara, K. Nobutomo, S. Kashiwagi

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Influenza vaccine is recommended for the elderly, a high-risk group for influenza infection. Unlike in many developed countries, the rate of influenza vaccination is extremely low in Japan. One of the primary reasons for this low level of vaccination use may be insufficient study on the cost-effectiveness of influenza vaccination in Japan. We determined the cost of medical tests and medications for inpatients with influenza in a referred hospital. We compared the medical costs by (1) level of daily life activity, (2) presence of pneumonia, and (3) living/dead status, 9 months after the infection. In addition, we set up a control group of patients for comparison of their medical costs to those of the influenza patients. Mean costs were 37,279 (+/- 26,784) yen for patients, and 2,361 (+/- 4,893) yen for controls. Mean costs were 32,424 (+/- 30,935) yen for inpatients without limitations to activity, 44,075 (+/- 20,937) yen for bed-bound inpatients, 44,614 (+/- 28,609) yen for inpatients with pneumonia, 27,009 (+/- 22,783) yen for inpatients without pneumonia, 57,624 (+/- 21,041) yen for inpatients who died within 9 months of the onset of influenza, and 16,934 (+/- 11,920) yen for inpatients who were alive 9 month after influenza infection.

Original languageEnglish
Pages (from-to)689-693
Number of pages5
JournalKansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases
Volume73
Issue number7
DOIs
Publication statusPublished - Jan 1 1999

Fingerprint

Human Influenza
Inpatients
Costs and Cost Analysis
Pneumonia
Vaccination
Japan
Infection
Influenza Vaccines
Developed Countries
Cost-Benefit Analysis
Control Groups

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Cost of medication for influenza infected elderly inpatients. / Hara, Y.; Ikematu, H.; Nabeshima, A.; Hagihara, Akihito; Nobutomo, K.; Kashiwagi, S.

In: Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, Vol. 73, No. 7, 01.01.1999, p. 689-693.

Research output: Contribution to journalArticle

Hara, Y. ; Ikematu, H. ; Nabeshima, A. ; Hagihara, Akihito ; Nobutomo, K. ; Kashiwagi, S. / Cost of medication for influenza infected elderly inpatients. In: Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases. 1999 ; Vol. 73, No. 7. pp. 689-693.
@article{7b48d1fe1acd442098276dc8450f1491,
title = "Cost of medication for influenza infected elderly inpatients",
abstract = "Influenza vaccine is recommended for the elderly, a high-risk group for influenza infection. Unlike in many developed countries, the rate of influenza vaccination is extremely low in Japan. One of the primary reasons for this low level of vaccination use may be insufficient study on the cost-effectiveness of influenza vaccination in Japan. We determined the cost of medical tests and medications for inpatients with influenza in a referred hospital. We compared the medical costs by (1) level of daily life activity, (2) presence of pneumonia, and (3) living/dead status, 9 months after the infection. In addition, we set up a control group of patients for comparison of their medical costs to those of the influenza patients. Mean costs were 37,279 (+/- 26,784) yen for patients, and 2,361 (+/- 4,893) yen for controls. Mean costs were 32,424 (+/- 30,935) yen for inpatients without limitations to activity, 44,075 (+/- 20,937) yen for bed-bound inpatients, 44,614 (+/- 28,609) yen for inpatients with pneumonia, 27,009 (+/- 22,783) yen for inpatients without pneumonia, 57,624 (+/- 21,041) yen for inpatients who died within 9 months of the onset of influenza, and 16,934 (+/- 11,920) yen for inpatients who were alive 9 month after influenza infection.",
author = "Y. Hara and H. Ikematu and A. Nabeshima and Akihito Hagihara and K. Nobutomo and S. Kashiwagi",
year = "1999",
month = "1",
day = "1",
doi = "10.11150/kansenshogakuzasshi1970.73.689",
language = "English",
volume = "73",
pages = "689--693",
journal = "Nippon Densenbyo Gakkai zasshi",
issn = "0387-5911",
publisher = "Nihon Kansensho Gakkai",
number = "7",

}

TY - JOUR

T1 - Cost of medication for influenza infected elderly inpatients

AU - Hara, Y.

AU - Ikematu, H.

AU - Nabeshima, A.

AU - Hagihara, Akihito

AU - Nobutomo, K.

AU - Kashiwagi, S.

PY - 1999/1/1

Y1 - 1999/1/1

N2 - Influenza vaccine is recommended for the elderly, a high-risk group for influenza infection. Unlike in many developed countries, the rate of influenza vaccination is extremely low in Japan. One of the primary reasons for this low level of vaccination use may be insufficient study on the cost-effectiveness of influenza vaccination in Japan. We determined the cost of medical tests and medications for inpatients with influenza in a referred hospital. We compared the medical costs by (1) level of daily life activity, (2) presence of pneumonia, and (3) living/dead status, 9 months after the infection. In addition, we set up a control group of patients for comparison of their medical costs to those of the influenza patients. Mean costs were 37,279 (+/- 26,784) yen for patients, and 2,361 (+/- 4,893) yen for controls. Mean costs were 32,424 (+/- 30,935) yen for inpatients without limitations to activity, 44,075 (+/- 20,937) yen for bed-bound inpatients, 44,614 (+/- 28,609) yen for inpatients with pneumonia, 27,009 (+/- 22,783) yen for inpatients without pneumonia, 57,624 (+/- 21,041) yen for inpatients who died within 9 months of the onset of influenza, and 16,934 (+/- 11,920) yen for inpatients who were alive 9 month after influenza infection.

AB - Influenza vaccine is recommended for the elderly, a high-risk group for influenza infection. Unlike in many developed countries, the rate of influenza vaccination is extremely low in Japan. One of the primary reasons for this low level of vaccination use may be insufficient study on the cost-effectiveness of influenza vaccination in Japan. We determined the cost of medical tests and medications for inpatients with influenza in a referred hospital. We compared the medical costs by (1) level of daily life activity, (2) presence of pneumonia, and (3) living/dead status, 9 months after the infection. In addition, we set up a control group of patients for comparison of their medical costs to those of the influenza patients. Mean costs were 37,279 (+/- 26,784) yen for patients, and 2,361 (+/- 4,893) yen for controls. Mean costs were 32,424 (+/- 30,935) yen for inpatients without limitations to activity, 44,075 (+/- 20,937) yen for bed-bound inpatients, 44,614 (+/- 28,609) yen for inpatients with pneumonia, 27,009 (+/- 22,783) yen for inpatients without pneumonia, 57,624 (+/- 21,041) yen for inpatients who died within 9 months of the onset of influenza, and 16,934 (+/- 11,920) yen for inpatients who were alive 9 month after influenza infection.

UR - http://www.scopus.com/inward/record.url?scp=0033162238&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033162238&partnerID=8YFLogxK

U2 - 10.11150/kansenshogakuzasshi1970.73.689

DO - 10.11150/kansenshogakuzasshi1970.73.689

M3 - Article

C2 - 10481405

AN - SCOPUS:0033162238

VL - 73

SP - 689

EP - 693

JO - Nippon Densenbyo Gakkai zasshi

JF - Nippon Densenbyo Gakkai zasshi

SN - 0387-5911

IS - 7

ER -